Gene therapy reduced risk of excessive bleeding for people with hemophilia B, early trial data suggests

A one-time novel gene therapy can reduce the risk of excessive bleeding in people with the bleeding disorder hemophilia B, who typically would need repeat therapies to reduce their risk, according to results from a Phase 1-2 trial.

from CNN.com - RSS Channel https://ift.tt/KVWwXk7